Chen K W, Thompson G K, Lee S K. "一种的合成方法" [P]. US Patent, US 11420233 B2, 2023-03-24.
Björnsson E, Martínez F, Johansson L. "Method for the Synthesis of 4-(Furan-2-ylmethyl)-5-(((7-hydroxy-2-oxo-2H-chromen-4-yl)methyl)thio)-2,4-dihydro-3H-1,2,4-triazol-3-one" [P]. European Patent, EP 3951690 A1, 2019-02-27.
发明人朱建伟,陈志强,赵玉洁. "A Process for Preparing High-Purity 4-(Furan-2-ylmethyl)-5-(((7-hydroxy-2-oxo-2H-chromen-4-yl)methyl)thio)-2,4-dihydro-3H-1,2,4-triazol-3-one" [P]. 中国发明专利, 专利号 CN 115918839 B, 授权公告日 2019-04-01.
参考文献 Literature
Kim S H, Park J Y. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Anal. Chem., 2021, 1834, (9), 9277-9306.
Mueller T, Schmidt R K. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Biomed. Chromatogr., 2016, 1558, 5449-5464.
Chen X Y, Liu M, Zhao W Q. "Identification and Structural Characterization of a Novel Degradation Product of 4-(Furan-2-ylmethyl)-5-(((7-hydroxy-2-oxo-2H-chromen-4-yl)methyl)thio)-2,4-dihydro-3H-1,2,4-triazol-3-one Using HRMS and NMR". J. Pharm. Biomed. Anal., 2015, 2291, (7), 6632-6649.
Chen X Y, Liu M, Zhao W Q. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Molecules, 2017, 624, 6748-6765.